Treatment of hepatitis C using direct-acting antiviral (DAA) agents in patients undergoing liver transplantation

Treatment of hepatitis C using direct-acting antiviral (DAA) agents in patients undergoing liver transplantation

.

Bibliographic Details
Main Authors:	V. E. Syutkin, A. A. Salienko, M. S. Novruzbekov
Format:	Article
Language:	English
Published:	N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Healthcare Department 2016-02-01
Series:	Transplantologiâ
Online Access:	https://www.jtransplantologiya.ru/jour/article/view/75

Similar Items

The use of telaprevir for the treatment of hepatitis C in patients undergoing liver transplantation (Literature review and clinical experience)
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

Successful Treatment of Hepatitis C Virus Infection Using Direct-Acting Antiviral Agents (DAAs) in Adolescents with Kidney Transplantation: A Case Series
by: Ambarsari CG, et al.
Published: (2020-06-01)

DEVELOPMENT AND APPROBATION METHOD OF IDENTIFICATION MUTATIONS THE RESISTANCE OF THE HEPATITIS C VIRUS TO DIRECT-ACTING ANTIVIRAL AGENTS (DAAs)
by: D. E. Valutite, et al.
Published: (2018-12-01)

CHALLENGES AND PERSPECTIVES IN HEPATITIS C VIRUS (HCV) RESEARCH IN AN ERA OF DIRECT ACTING ANTIVIRAL (DAA) THERAPY
by: A. Budkowska
Published: (2018-12-01)

The use of sofosbuvir for the treatment of recurrent hepatitis C after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2017-03-01)

Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantation.
by: Julia M Grottenthaler, et al.
Published: (2018-01-01)

POSSIBILITIES OF HEPATITIS C ANTIVIRAL TREATMENT IN LIVER TRANSPLANT RECIPIENTS
by: V. E. Syutkin, et al.
Published: (2011-06-01)

CMV-infection in patients after liver transplantation
by: M. Sh. Khubutiya, et al.
Published: (2016-02-01)

HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the Elderly
by: Stefania Brozzetti, et al.
Published: (2021-06-01)

Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)
by: Haitham A. Azeem, et al.
Published: (2021-06-01)

Clinical efficacy of direct-acting antiviral agents in treatment of patients with hepatitis C recurrence after liver transplantation
by: LIU Hongling, et al.
Published: (2015-12-01)

Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C
by: Chung Sang Tse, et al.
Published: (2021-01-01)

TREATMENT OF HEPATITIS C WITHOUT INTERFERON IN PATIENTS UNDERGOING LIVER TRANSPLANTATION
by: M. Sh. Khubutia, et al.
Published: (2015-10-01)

Treatment of hepatitis C in HIV/HCV co-infected with direct-acting antiviral (DAA) regimens in a single clinic in Tripoli/Libya
by: N. Bousifi, et al.
Published: (2020-12-01)

EVALUATION OF LIVER FIBROSIS AND CAROTID INTIMA-MEDIA THICKNESS INDEX (C-IMT) IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS BEFORE AND AFTER DIRECT-ACTING ANTIVIRAL TREATMENT (DAA)
by: Raluca Mihaela Dîrțu, et al.
Published: (2021-06-01)

Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs
by: Claudia Minosse, et al.
Published: (2021-06-01)

P29 Treating hepatitis C virus infection (HCV) with direct acting antivirals (DAAs) through the existing infrastructure of opioid agonist therapy (OAT)
by: J. Keats, et al.
Published: (2017-08-01)

Efficiency of Antiviral Therapy for Recurrence of Chronic Hepatitis C in Patients Undergoing Liver Transplantation
by: A. A. Sukhoruk, et al.
Published: (2014-09-01)

Treatment of hepatitis C in liver transplant recipients in the Moscow Center for Liver Transplantation within 10 years
by: M. Sh. Khubutia, et al.
Published: (2016-01-01)

Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland
by: Karoline Aebi-Popp, et al.
Published: (2016-01-01)

Treatment of chronic viral hepatitis C with direct acting antiviral agent: review
by: V A Malov, et al.
Published: (2019-11-01)

Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis
by: Jennifer Wellington, et al.
Published: (2021-09-01)

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma
by: Yumiko Nagao, et al.
Published: (2017-11-01)

Real-World Results of Direct-Acting Antiviral Agents for Chronic Hepatitis C
by: Chun-Ming Hong, et al.
Published: (2018)

Mechanism of action of direct-acting antiviral agents in treatment of chronic hepatitis C
by: WEN Xiaoyu, et al.
Published: (2016-09-01)

Current research on hepatitis C virus resistance to direct-acting antiviral agents
by: REN Shan, et al.
Published: (2015-11-01)

Reactivation of herpesvirus in patients with hepatitis C treated with direct-acting antiviral agents
by: Ghweil AA, et al.
Published: (2019-04-01)

Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents
by: L.P. Zanaga, et al.

Cost-effectiveness of a "treat-all" strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages.
by: Riichiro Suenaga, et al.
Published: (2021-01-01)

Treatment of the chronic hepatitis C complicated by mixed cryoglobulinemia with direct-acting antiviral agents
by: N. V. Dunaeva, et al.
Published: (2018-12-01)

Recurrent hepatitis C treatment with direct acting antivirals – a real life study at a Brazilian liver transplant center
by: L.P. Zanaga, et al.

The effect of early everolimus administration on the renal function while reducing the dosage of calcineurin inhibitors in liver transplant recipients in a long-term follow-up
by: V. E. Syutkin, et al.
Published: (2021-06-01)

Direct Acting Antivirals for Treatment of Hepatitis C Infection in Patients with Advanced Liver Disease
by: Woo Jin Chung
Published: (2016-01-01)

Association of direct-acting antiviral therapy for hepatitis C with the development and recurrence of liver cancer
by: LI Yan
Published: (2018-02-01)

Hepatitis C virus cell-cell transmission and resistance to direct-acting antiviral agents.
by: Fei Xiao, et al.
Published: (2014-05-01)

New treatment of hepatitis C (Direct Acting Antiviral)
by: Mohsen Akhondi-Meybodi
Published: (2019-10-01)

Vaccination against viral hepatitis B in patients undergoing liver transplantation for hepatitis B-unassociated causes
by: V. E. Syutkin, et al.
Published: (2018-08-01)

SASLT position statement on the direct-acting antiviral agents for the treatment of hepatitis C virus infection
by: Abdullah S Alghamdi, et al.
Published: (2015-01-01)

Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series Analysis
by: Ahmad Shakeri, et al.
Published: (2021-07-01)

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus
by: Tavares RCF, et al.
Published: (2018-10-01)